Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Early determinants of type-2 diabetes.

Berends LM, Ozanne SE.

Best Pract Res Clin Endocrinol Metab. 2012 Oct;26(5):569-80. doi: 10.1016/j.beem.2012.03.002. Epub 2012 May 22. Review.

PMID:
22980041
2.

Genetic, nongenetic and epigenetic risk determinants in developmental programming of type 2 diabetes.

Vaag A, Brøns C, Gillberg L, Hansen NS, Hjort L, Arora GP, Thomas N, Broholm C, Ribel-Madsen R, Grunnet LG.

Acta Obstet Gynecol Scand. 2014 Nov;93(11):1099-108. doi: 10.1111/aogs.12494. Epub 2014 Sep 30. Review.

PMID:
25179736
3.

[The transgenerational mechanisms in developmental programming of metabolic diseases].

Zambrano E.

Rev Invest Clin. 2009 Jan-Feb;61(1):41-52. Review. Spanish.

PMID:
19507474
4.

Metabolic programming, epigenetics, and gestational diabetes mellitus.

Pinney SE, Simmons RA.

Curr Diab Rep. 2012 Feb;12(1):67-74. doi: 10.1007/s11892-011-0248-1. Review.

PMID:
22127642
5.

Fetal determinants of type 2 diabetes.

Reusens B, Ozanne SE, Remacle C.

Curr Drug Targets. 2007 Aug;8(8):935-41. Review.

PMID:
17691930
6.

Early life factors and type 2 diabetes mellitus.

Jiang X, Ma H, Wang Y, Liu Y.

J Diabetes Res. 2013;2013:485082. doi: 10.1155/2013/485082. Epub 2013 Dec 16. Review.

7.

Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus.

Boney CM, Verma A, Tucker R, Vohr BR.

Pediatrics. 2005 Mar;115(3):e290-6.

PMID:
15741354
8.

Maternal and in utero determinants of type 2 diabetes risk in the young.

Bruce KD.

Curr Diab Rep. 2014 Jan;14(1):446. doi: 10.1007/s11892-013-0446-0. Review.

PMID:
24292969
9.

Fetal development and risk of cardiovascular diseases and diabetes type 2 in adult life.

Szostak-Węgierek D, Szamotulska K.

Med Wieku Rozwoj. 2011 Jul-Sep;15(3):203-15. Review.

10.

Glucocorticoid excess and the developmental origins of disease: two decades of testing the hypothesis--2012 Curt Richter Award Winner.

Reynolds RM.

Psychoneuroendocrinology. 2013 Jan;38(1):1-11. doi: 10.1016/j.psyneuen.2012.08.012. Epub 2012 Sep 19. Review.

PMID:
22998948
11.
12.

Maternal environment and the transgenerational cycle of obesity and diabetes.

Dabelea D, Crume T.

Diabetes. 2011 Jul;60(7):1849-55. doi: 10.2337/db11-0400. Review. No abstract available.

13.
14.

A critical review: early life nutrition and prenatal programming for adult disease.

Carolan-Olah M, Duarte-Gardea M, Lechuga J.

J Clin Nurs. 2015 Dec;24(23-24):3716-29. doi: 10.1111/jocn.12951. Epub 2015 Aug 9. Review.

PMID:
26255862
15.

[Foetal programming of nutrition-related chronic diseases].

Delisle H.

Sante. 2002 Jan-Mar;12(1):56-63. Review. French.

16.

Recent developments on the role of epigenetics in obesity and metabolic disease.

van Dijk SJ, Tellam RL, Morrison JL, Muhlhausler BS, Molloy PL.

Clin Epigenetics. 2015 Jul 11;7:66. doi: 10.1186/s13148-015-0101-5. eCollection 2015. Review.

17.

Early-life exposure to substance abuse and risk of type 2 diabetes in adulthood.

Vaiserman AM.

Curr Diab Rep. 2015 Aug;15(8):48. doi: 10.1007/s11892-015-0624-3. Review.

PMID:
26077016
18.

Developmental origins of obesity and type 2 diabetes: molecular aspects and role of chemicals.

Inadera H.

Environ Health Prev Med. 2013 May;18(3):185-97. doi: 10.1007/s12199-013-0328-8. Epub 2013 Feb 5. Review.

19.

Metabolic programming of insulin action and secretion.

Martin-Gronert MS, Ozanne SE.

Diabetes Obes Metab. 2012 Oct;14 Suppl 3:29-39. doi: 10.1111/j.1463-1326.2012.01653.x. Review.

PMID:
22928562
20.

Supplemental Content

Support Center